220 related articles for article (PubMed ID: 23614202)
21. A review of apixaban for stroke prevention in atrial fibrillation: insights from ARISTOTLE.
Hess CN; Al-Khatib SM; Granger CB; Lopes R
Expert Rev Cardiovasc Ther; 2013 Sep; 11(9):1105-14. PubMed ID: 23992517
[TBL] [Abstract][Full Text] [Related]
22. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
Berman JP; Halperin JL
Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966
[TBL] [Abstract][Full Text] [Related]
23. Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
Lip GY; Connolly S; Yusuf S; Shestakovska O; Flaker G; Hart R; Lanas F; Xavier D; Eikelboom J;
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):31-8. PubMed ID: 23390125
[TBL] [Abstract][Full Text] [Related]
24. Apixaban in patients with atrial fibrillation.
Lynch DR
N Engl J Med; 2011 Jun; 364(24):2362-3; author reply 2363-4. PubMed ID: 21675902
[No Abstract] [Full Text] [Related]
25. A review of oral anticoagulants in patients with atrial fibrillation.
Greenspon AJ
Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
[TBL] [Abstract][Full Text] [Related]
26. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
Agarwal S; Hachamovitch R; Menon V
Arch Intern Med; 2012 Apr; 172(8):623-31; discussion 631-3. PubMed ID: 22450212
[TBL] [Abstract][Full Text] [Related]
27. Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation.
Belavic JM
Nurse Pract; 2011 Sep; 36(9):6-7. PubMed ID: 21857210
[No Abstract] [Full Text] [Related]
28. Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial.
Ng KH; Shestakovska O; Connolly SJ; Eikelboom JW; Avezum A; Diaz R; Lanas F; Yusuf S; Hart RG
Age Ageing; 2016 Jan; 45(1):77-83. PubMed ID: 26590293
[TBL] [Abstract][Full Text] [Related]
29. Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.
Qamar A; Bhatt DL
Circulation; 2016 Apr; 133(15):1512-5. PubMed ID: 27067086
[No Abstract] [Full Text] [Related]
30. Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy: Insights From the ARISTOTLE Trial.
Al-Khatib SM; Mulder H; Wojdyla D; Lopes RD; Wallentin L; Alexander JH; Hijazi Z; Goto S; Granger CB
Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009614. PubMed ID: 33657831
[No Abstract] [Full Text] [Related]
31. Adjusted indirect comparison of new oral anticoagulants for stroke prevention in atrial fibrillation.
Testa L; Agnifili M; Latini RA; Mattioli R; Lanotte S; De Marco F; Oreglia J; Latib A; Pizzocri S; Laudisa ML; Brambilla N; Bedogni F
QJM; 2012 Oct; 105(10):949-57. PubMed ID: 22771555
[TBL] [Abstract][Full Text] [Related]
32. A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.
Kasmeridis C; Lip GY; Apostolakis S
Hosp Pract (1995); 2013 Feb; 41(1):61-70. PubMed ID: 23466968
[TBL] [Abstract][Full Text] [Related]
33. [Effective anticoagulation also in advanced age].
Zimmermann W
MMW Fortschr Med; 2015 Feb; 157(3):72. PubMed ID: 25743684
[No Abstract] [Full Text] [Related]
34. European Society of Cardiology congress 2011.
Cardiovasc J Afr; 2011; 22(5):287-8, 291-2. PubMed ID: 21983959
[No Abstract] [Full Text] [Related]
35. [The ARISTOTLE study].
Di Pasquale G; De Caterina R
G Ital Cardiol (Rome); 2012 Sep; 13(9):557-62. PubMed ID: 22825340
[No Abstract] [Full Text] [Related]
36. Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation.
Lenchus JD
Hosp Pract (1995); 2013 Feb; 41(1):49-60. PubMed ID: 23466967
[TBL] [Abstract][Full Text] [Related]
37. Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect.
Guimarães PO; Lopes RD; Wojdyla DM; Abdul-Rahim AH; Connolly SJ; Flaker GC; Wang J; Hanna M; Granger CB; Wallentin L; Lees KR; Alexander JH; McMurray JJV
Cardiovasc Drugs Ther; 2017 Jun; 31(3):295-301. PubMed ID: 28516318
[TBL] [Abstract][Full Text] [Related]
38. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
39. A new era for anticoagulation in atrial fibrillation.
Mega JL
N Engl J Med; 2011 Sep; 365(11):1052-4. PubMed ID: 21870977
[No Abstract] [Full Text] [Related]
40. Apixaban versus warfarin in atrial fibrillation.
Vassiliou VS
N Engl J Med; 2012 Jan; 366(1):88; author reply 89. PubMed ID: 22216849
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
